Shares of Mitek (MITK) have resumed trading down 40%
Shares of Mitek (Nasdaq: MITK) have resumed trading down 40%
You May Also Be Interested In
- Nektar Therapeutics (NKTR) Wins FDA Approval of Movanik
- Endo (ENDP) Makes $28.10/Share Bid for Auxilium Pharma (AUXL)
- ReWalk Robotics (RWLK) IPO Adds to Gains Pre-Open
Create E-mail Alert Related CategoriesTrading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!